UNIGE document Professional Article
previous document  unige:112331  next document
add to browser collection

[Hormonal treatments and venous thrombosis in women]

Hugon-Rodin, Justine
Plu-Bureau, Geneviève
Streuli, Isabelle
Published in Revue médicale suisse. 2017, vol. 13, no. 580, p. 1821-1825
Abstract Venous thromboembolism is frequently associated with hormonal factors in women. A thorough medical history taking of vascular risks and an individual evaluation of the risk-benefit ratio should precede any prescription of hormonal therapies. In contrary to progestin-only-pills, estroprogestative contraceptives increase 3-6 times the risk of venous thrombosis. In assisted reproductive techniques, venous thrombosis is frequently associated with the occurrence of a severe ovarian hyperstimulation syndrome. Antagonist ovarian stimulation protocols lower the risk of hyperstimulation and should therefore be preferred. Finally, at menopause, hormonal treatments combining transdermal estradiol and micronized progesterone do not seem to increment the risk of thrombosis.
PMID: 29071830
Full text
Article (Published version) (102 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group La maladie thromboembolique veineuse (808)
(ISO format)
HUGON-RODIN, Justine et al. [Hormonal treatments and venous thrombosis in women]. In: Revue médicale suisse, 2017, vol. 13, n° 580, p. 1821-1825. https://archive-ouverte.unige.ch/unige:112331

34 hits

0 download


Deposited on : 2018-12-14

Export document
Format :
Citation style :